account_id none on file
legal_name Avalo Therapeutics, Inc.
ticker AVTX
cik 1534120
domain avalotx.com
linkedin_company_url https://www.linkedin.com/company/avalotx
entry_point_account_id none on file
name Avalo Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Wayne, PA, United States
sector index/company/sector/health-care/
calls 0 filings 22 executives 4 family 0
why_nownone on file
callsnone on file
filings
Additionally, Avalo had an operating lease for administrative office space in Rockville, Maryland, which the Company elected to early-terminate effective January 31, 2026 by providing notice and paying the $ 0.3 million contractual early termination fee in the fourth quarter of 2024, resulting in a remeasurement and reduction of the lease liability and right-of-use (“ROU”) asset by $ 0.3 million.
filing / Aug 6, 2026 / receipt
Salaries, benefits and related costs increased $0.7 million compared to the three months ended March 31, 2025 due primarily to headcount additions during the year.
filing / May 13, 2026 / receipt
The increase in general and administrative expenses from the prior year period was driven by a $0.6 million increase in salaries, benefits and related costs compared to the prior year due primarily to headcount additions.
filing / May 13, 2026 / receipt
Additionally, Avalo had an operating lease for administrative office space in Rockville, Maryland, which the Company elected to early-terminate effective January 31, 2026 by providing notice and paying the $ 0.3 million contractual early termination fee in the fourth quarter of 2024, resulting in a remeasurement and reduction of the lease liability and right-of-use (“ROU”) asset by $ 0.3 million.
filing / May 13, 2026 / receipt
Sr. Manager, Quality Systems and Compliance Technology | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4341798009", "remote": false, "category": "other", "function": "legal",
company_statement / Sep 16, 2026 / receipt
Director Analytical Development | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4396185009", "remote": false, "category": "other", "function": "other", "location": "Chesterbr
company_statement / Sep 10, 2026 / receipt
Dir./Sr. Director, Upstream Biologics Manufacturing | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4394253009", "remote": false, "category": "other", "function": "other", "l
company_statement / Sep 4, 2026 / receipt
Dir./Sr. Director, Downstream Biologics Manufacturing | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4394275009", "remote": false, "category": "other", "function": "other",
company_statement / Sep 4, 2026 / receipt
Senior Manager, SEC Reporting | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4375281009", "remote": false, "category": "other", "function": "other", "location": "Chesterbroo
company_statement / Aug 21, 2026 / receipt
Supply Chain Lead | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4375305009", "remote": false, "category": "other", "function": "operations", "location": "Chesterbrook, PA",
company_statement / Aug 20, 2026 / receipt
Medical Director/Sr. Medical Director, Clinical Development- Dermatology | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4360075009", "remote": false, "category": "other", "f
company_statement / Aug 13, 2026 / receipt
Sr. Clinical Scientist | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4360685009", "remote": false, "category": "other", "function": "clinical", "location": "Chesterbrook, P
company_statement / Aug 10, 2026 / receipt
executives
| Garry A. Neil | President and Chief Executive Officer | - | receipt |
| Michael Cola | Chairman of the Board | - | receipt |
| Peter Greenleaf | Chief Executive Officer | - | receipt |
| Simon Pedder | Executive Chairman of the Board | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2022-02-18 | President and Chief Executive Officer, appointed | sec_8k |
| 2022-02-08 | Chief Medical Officer, departed | sec_8k |
| 2021-06-21 | Chairman of the Board, appointed | sec_8k |
| 2019-04-12 | Executive Chairman of the Board, appointed | sec_8k |
| 2018-07-16 | Chief Financial Officer, departed | sec_8k |
| 2018-04-02 | Chief Executive Officer, appointed | sec_8k |
mcp_package_hint
slug avalo-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$